Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
pegvisomant
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
pegvisomant
Unique ID
C406545
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C406545
Entry Term(s)
B-2036 PEG
B2036-PEG
Somavert
Registry Numbers
N824AOU5XV
0
Heading Mapped to
Human Growth Hormone
/
analogs & derivatives
Frequency
413
Note
is a genetically engineered analogue of human growth hormone that functions as a growth hormone-receptor antagonist; used to treat Acromegaly;
Source
N Engl J Med 2000 Apr 20;342(16):1171-7
Indexing Information
Acromegaly
Receptors, Somatotropin
Date of Entry
2000/04/18
Revision Date
2016/08/26
Expand All
Collapse All
pegvisomant
Preferred
Concept UI
M0360672
Registry Numbers
N824AOU5XV
Terms
pegvisomant
Preferred Term
Term UI
T412077
Date
04/18/2000
LexicalTag
NON
ThesaurusID
B2036-PEG
Narrower
Concept UI
M0306430
Registry Numbers
0
Terms
B2036-PEG
Preferred Term
Term UI
T336435
Date
01/01/1955
LexicalTag
LAB
ThesaurusID
NLM (2000)
B-2036 PEG
Term UI
T336434
Date
01/01/1955
LexicalTag
NON
ThesaurusID
NLM (2000)
Somavert
Narrower
Concept UI
M0446720
Registry Numbers
0
Terms
Somavert
Preferred Term
Term UI
T535026
Date
03/11/2003
LexicalTag
TRD
ThesaurusID
page delivered in 0.004s